Anthony Peter Weiss, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 22 | 2009 | 6882 | 0.990 |
Why?
|
| Schizophrenic Psychology | 11 | 2008 | 1678 | 0.920 |
Why?
|
| Hippocampus | 11 | 2006 | 3675 | 0.590 |
Why?
|
| Verbal Learning | 5 | 2008 | 467 | 0.580 |
Why?
|
| Mental Recall | 7 | 2008 | 1205 | 0.540 |
Why?
|
| Memory Disorders | 5 | 2008 | 1184 | 0.490 |
Why?
|
| Psychiatric Department, Hospital | 1 | 2013 | 135 | 0.440 |
Why?
|
| Medical Staff, Hospital | 2 | 2013 | 603 | 0.410 |
Why?
|
| Prefrontal Cortex | 4 | 2009 | 2147 | 0.330 |
Why?
|
| Mental Disorders | 6 | 2014 | 6600 | 0.300 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2008 | 284 | 0.280 |
Why?
|
| Speech Acoustics | 1 | 2007 | 151 | 0.280 |
Why?
|
| Association Learning | 2 | 2007 | 224 | 0.280 |
Why?
|
| Dominance, Cerebral | 3 | 2005 | 635 | 0.260 |
Why?
|
| Magnetoencephalography | 1 | 2009 | 623 | 0.260 |
Why?
|
| Attention | 6 | 2008 | 2400 | 0.250 |
Why?
|
| Length of Stay | 4 | 2012 | 6309 | 0.250 |
Why?
|
| Psychiatry | 3 | 2012 | 1695 | 0.240 |
Why?
|
| Parietal Lobe | 1 | 2009 | 838 | 0.240 |
Why?
|
| Auditory Cortex | 1 | 2008 | 346 | 0.240 |
Why?
|
| Oxygen Consumption | 2 | 2008 | 1869 | 0.230 |
Why?
|
| Efficiency | 1 | 2007 | 462 | 0.230 |
Why?
|
| Health Services | 1 | 2009 | 758 | 0.230 |
Why?
|
| Auditory Perception | 1 | 2008 | 569 | 0.220 |
Why?
|
| Health Personnel | 1 | 2016 | 3218 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2009 | 35421 | 0.210 |
Why?
|
| Speech Perception | 1 | 2007 | 489 | 0.210 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 6489 | 0.210 |
Why?
|
| Antipsychotic Agents | 4 | 2011 | 3057 | 0.210 |
Why?
|
| Medicare Part B | 1 | 2023 | 108 | 0.200 |
Why?
|
| Cognition Disorders | 5 | 2007 | 4043 | 0.200 |
Why?
|
| Hemoglobins | 1 | 2008 | 1534 | 0.200 |
Why?
|
| Menthol | 1 | 2001 | 26 | 0.200 |
Why?
|
| Health Services Needs and Demand | 1 | 2009 | 1411 | 0.190 |
Why?
|
| Frontal Lobe | 2 | 2006 | 1406 | 0.190 |
Why?
|
| Pattern Recognition, Visual | 2 | 2005 | 824 | 0.190 |
Why?
|
| Nonprescription Drugs | 1 | 2001 | 116 | 0.180 |
Why?
|
| Hypericum | 1 | 1999 | 58 | 0.180 |
Why?
|
| Computer Simulation | 1 | 2013 | 6196 | 0.180 |
Why?
|
| Memory | 3 | 2009 | 2174 | 0.170 |
Why?
|
| Decision Making | 1 | 2013 | 3887 | 0.170 |
Why?
|
| Plants, Medicinal | 1 | 1999 | 167 | 0.170 |
Why?
|
| Attitude of Health Personnel | 2 | 2012 | 3843 | 0.170 |
Why?
|
| Emergency Service, Hospital | 3 | 2014 | 7659 | 0.160 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2001 | 365 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 2731 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2004 | 975 | 0.150 |
Why?
|
| Hallucinations | 1 | 1999 | 360 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3610 | 0.140 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2008 | 245 | 0.140 |
Why?
|
| Quality of Health Care | 2 | 2009 | 4371 | 0.140 |
Why?
|
| Tomography, Emission-Computed | 4 | 2003 | 1144 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2012 | 4468 | 0.130 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 2002 | 1444 | 0.120 |
Why?
|
| Cognition | 4 | 2008 | 6770 | 0.110 |
Why?
|
| Medical Audit | 2 | 2012 | 467 | 0.110 |
Why?
|
| Adult | 30 | 2014 | 214055 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2004 | 2921 | 0.110 |
Why?
|
| Male | 36 | 2014 | 350118 | 0.110 |
Why?
|
| Middle Aged | 27 | 2014 | 213383 | 0.110 |
Why?
|
| Nicotine | 2 | 2008 | 681 | 0.110 |
Why?
|
| Polymorphism, Genetic | 3 | 2008 | 4328 | 0.110 |
Why?
|
| Neuropsychological Tests | 7 | 2008 | 6993 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 9959 | 0.100 |
Why?
|
| Humans | 47 | 2023 | 744343 | 0.100 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2012 | 68 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2013 | 23338 | 0.100 |
Why?
|
| Facial Expression | 2 | 2005 | 508 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2006 | 8949 | 0.100 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2011 | 93 | 0.100 |
Why?
|
| Research Design | 1 | 2007 | 5987 | 0.100 |
Why?
|
| Crowding | 1 | 2012 | 145 | 0.100 |
Why?
|
| Alcoholism | 1 | 2001 | 1906 | 0.090 |
Why?
|
| Hospitals, Psychiatric | 1 | 2011 | 332 | 0.090 |
Why?
|
| Reality Testing | 1 | 2008 | 26 | 0.080 |
Why?
|
| Semantics | 2 | 2003 | 584 | 0.080 |
Why?
|
| Association | 1 | 2008 | 53 | 0.080 |
Why?
|
| Parahippocampal Gyrus | 2 | 2005 | 116 | 0.080 |
Why?
|
| Female | 27 | 2014 | 380194 | 0.080 |
Why?
|
| Analysis of Variance | 5 | 2011 | 6365 | 0.080 |
Why?
|
| Reference Values | 3 | 2005 | 4982 | 0.080 |
Why?
|
| Reaction Time | 4 | 2008 | 2097 | 0.080 |
Why?
|
| Radionuclide Imaging | 2 | 2002 | 2031 | 0.080 |
Why?
|
| Confidentiality | 1 | 2012 | 612 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 5751 | 0.080 |
Why?
|
| Recruitment, Neurophysiological | 2 | 2004 | 32 | 0.080 |
Why?
|
| Gyrus Cinguli | 2 | 2004 | 1091 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 1999 | 2838 | 0.080 |
Why?
|
| Time Factors | 7 | 2012 | 40075 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2005 | 5708 | 0.070 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 695 | 0.070 |
Why?
|
| Photic Stimulation | 3 | 2009 | 2025 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2014 | 6038 | 0.070 |
Why?
|
| Habituation, Psychophysiologic | 2 | 2005 | 154 | 0.070 |
Why?
|
| Behavioral Symptoms | 1 | 2007 | 175 | 0.070 |
Why?
|
| Visual Perception | 2 | 2005 | 1420 | 0.060 |
Why?
|
| Nerve Net | 3 | 2009 | 2174 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2011 | 2618 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2011 | 1183 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 271 | 0.060 |
Why?
|
| Community Mental Health Services | 1 | 2008 | 386 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2001 | 4258 | 0.060 |
Why?
|
| Brain Mapping | 4 | 2008 | 6669 | 0.060 |
Why?
|
| Patient Admission | 1 | 2012 | 1380 | 0.060 |
Why?
|
| Mathematical Computing | 1 | 2004 | 147 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2005 | 1953 | 0.060 |
Why?
|
| Awareness | 1 | 2008 | 640 | 0.060 |
Why?
|
| Temporal Lobe | 3 | 2005 | 1670 | 0.060 |
Why?
|
| Acoustic Stimulation | 1 | 2008 | 1216 | 0.060 |
Why?
|
| Stereotaxic Techniques | 2 | 2003 | 536 | 0.060 |
Why?
|
| Functional Laterality | 2 | 2008 | 2290 | 0.060 |
Why?
|
| Reading | 1 | 2007 | 558 | 0.060 |
Why?
|
| Telencephalon | 1 | 2003 | 142 | 0.060 |
Why?
|
| Outpatients | 1 | 2011 | 1486 | 0.060 |
Why?
|
| Word Association Tests | 1 | 2002 | 57 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 721 | 0.050 |
Why?
|
| Signal Detection, Psychological | 1 | 2002 | 85 | 0.050 |
Why?
|
| Bipolar Disorder | 1 | 1999 | 5027 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2007 | 705 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1405 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2012 | 6459 | 0.050 |
Why?
|
| Psychosurgery | 1 | 2002 | 87 | 0.050 |
Why?
|
| Benchmarking | 1 | 2008 | 1042 | 0.050 |
Why?
|
| Goals | 1 | 2007 | 706 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2011 | 21746 | 0.050 |
Why?
|
| Internet | 1 | 2013 | 3064 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2007 | 9146 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2012 | 1901 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15165 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2007 | 1683 | 0.050 |
Why?
|
| Lorazepam | 1 | 2001 | 145 | 0.050 |
Why?
|
| New England | 2 | 2014 | 1022 | 0.050 |
Why?
|
| Mental Health | 1 | 2014 | 3019 | 0.050 |
Why?
|
| Fear | 2 | 2005 | 1440 | 0.040 |
Why?
|
| Poisoning | 1 | 2001 | 249 | 0.040 |
Why?
|
| Limbic System | 1 | 2002 | 426 | 0.040 |
Why?
|
| Atrophy | 1 | 2004 | 1583 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2001 | 690 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 1525 | 0.040 |
Why?
|
| Fentanyl | 1 | 2001 | 410 | 0.040 |
Why?
|
| Research | 1 | 2007 | 1999 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2007 | 2682 | 0.040 |
Why?
|
| Amygdala | 1 | 2005 | 1315 | 0.040 |
Why?
|
| Oxygen | 2 | 2006 | 4189 | 0.040 |
Why?
|
| Brain | 2 | 2006 | 26385 | 0.040 |
Why?
|
| Brain Stem | 1 | 2002 | 846 | 0.040 |
Why?
|
| Lithium | 1 | 1999 | 601 | 0.040 |
Why?
|
| United States | 4 | 2023 | 69872 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2274 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2014 | 53288 | 0.030 |
Why?
|
| Administration, Cutaneous | 2 | 2008 | 711 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2006 | 2708 | 0.030 |
Why?
|
| Thalamus | 1 | 2001 | 1023 | 0.030 |
Why?
|
| Depressive Disorder, Major | 2 | 2003 | 4644 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2007 | 15540 | 0.030 |
Why?
|
| Age Factors | 1 | 2012 | 18370 | 0.030 |
Why?
|
| Aged | 6 | 2023 | 163280 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1107 | 0.030 |
Why?
|
| Cerebellum | 1 | 2001 | 1488 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7279 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2011 | 63114 | 0.030 |
Why?
|
| Emotions | 1 | 2005 | 2661 | 0.030 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2002 | 1018 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2006 | 9849 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2008 | 3046 | 0.030 |
Why?
|
| Genotype | 4 | 2008 | 12951 | 0.030 |
Why?
|
| Age of Onset | 1 | 2000 | 3271 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2008 | 4687 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 17446 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2008 | 2029 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2014 | 392 | 0.030 |
Why?
|
| Logistic Models | 1 | 2007 | 13408 | 0.030 |
Why?
|
| Comorbidity | 1 | 2006 | 10388 | 0.030 |
Why?
|
| Hospital Departments | 1 | 2012 | 137 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2008 | 15519 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3507 | 0.020 |
Why?
|
| Dopamine | 2 | 2008 | 1591 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2012 | 40561 | 0.020 |
Why?
|
| Massachusetts | 2 | 2014 | 8663 | 0.020 |
Why?
|
| Delirium | 1 | 2001 | 1609 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2011 | 348 | 0.020 |
Why?
|
| Pteroylpolyglutamic Acids | 1 | 2007 | 10 | 0.020 |
Why?
|
| Psychomotor Performance | 2 | 2007 | 1901 | 0.020 |
Why?
|
| Valine | 1 | 2008 | 413 | 0.020 |
Why?
|
| Methionine | 1 | 2008 | 590 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2007 | 339 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 23403 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 25043 | 0.020 |
Why?
|
| Happiness | 1 | 2005 | 170 | 0.020 |
Why?
|
| Homocysteine | 1 | 2007 | 647 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1791 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2008 | 12026 | 0.010 |
Why?
|
| Arousal | 1 | 2008 | 1165 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 1178 | 0.010 |
Why?
|
| Vocabulary | 1 | 2002 | 169 | 0.010 |
Why?
|
| Psychotherapy | 1 | 2011 | 1643 | 0.010 |
Why?
|
| Behavior | 1 | 2004 | 561 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 2759 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 3588 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2011 | 1643 | 0.010 |
Why?
|
| Risk Factors | 1 | 2006 | 72290 | 0.010 |
Why?
|
| Affect | 1 | 2007 | 1476 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4186 | 0.010 |
Why?
|
| Urinary Incontinence | 1 | 2002 | 496 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 20129 | 0.010 |
Why?
|
| Motor Cortex | 1 | 2004 | 986 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 3760 | 0.010 |
Why?
|
| Mood Disorders | 1 | 2002 | 1106 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 3647 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9687 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2005 | 2972 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2008 | 4286 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 29063 | 0.010 |
Why?
|
| Learning | 1 | 2002 | 1713 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 5078 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9583 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 16365 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15076 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 39050 | 0.000 |
Why?
|